Terauchi, Yasuo
Utsunomiya, Kazunori
Yasui, Atsutaka
Seki, Tetsuo
Cheng, Gang
Shiki, Kosuke
Lee, Jisoo
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study
https://doi.org/10.1007/s13300-019-0604-8
Funding for this research was provided by:
Boehringer Ingelheim; Eli Lilly and Company
Article History
Received: 15 February 2019
First Online: 25 March 2019